SKI Market

Indian Indices

Sensex

83,576.24 -604.72
( -0.72%)

Global Indices

Nasdaq

49,520.87 233.75
(0.47%)

Dow Jones

6,986.78 44.32
(0.64%)

Hang Seng

51,918.01 800.75
(1.57%)

Nikkei 225

10,123.15 78.46
(0.78%)

Forex

USD-INR

89.91 -0.02
(-0.02%)

EUR-INR

104.90 -0.20
(-0.19%)

GBP-INR

120.86 -0.43
(-0.35%)

JPY-INR

0.57 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sat Kartar Shopping Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

93343

INE0NB801022

32.7094199

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SATKARTAR

22.42

218.85

EPS(TTM)

Face Value()

Div & Yield %

6.2

0.5

Back

last mile enterprises ltd

Marksans Pharma consolidated net profit rises 1.58% in the September 2025 quarter

Nov 14,2025

Net profit of Marksans Pharma rose 1.58% to Rs 98.25 crore in the quarter ended September 2025 as against Rs 96.72 crore during the previous quarter ended September 2024. Sales rose 12.23% to Rs 720.41 crore in the quarter ended September 2025 as against Rs 641.92 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	720.41	641.92	12
OPM %	20.06	22.87	-
PBDT	160.25	144.11	11
PBT	133.33	124.60	7
NP	98.25	96.72	2

83,576.24 -604.72 ( -0.72%)

49,520.87 233.75 (0.47%)

6,986.78 44.32 (0.64%)

51,918.01 800.75 (1.57%)

10,123.15 78.46 (0.78%)

89.91 -0.02 (-0.02%)

104.90 -0.20 (-0.19%)

120.86 -0.43 (-0.35%)

0.57 0.00 (-0.15%)